Determination of EGFR and KRAS mutational status in Greek non-small-cell lung cancer patients

It has been reported that certain patients with non-small-cell lung cancer (NSCLC) that harbor activating somatic mutations within the tyrosine kinase domain of the epidermal growth factor receptor (EGFR) gene may be effectively treated using targeted therapy. The use of EGFR inhibitors in patient t...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncol Lett
Principais autores: PAPADOPOULOU, EIRINI, TSOULOS, NIKOLAOS, TSIRIGOTI, ANGELIKI, APESSOS, ANGELA, AGIANNITOPOULOS, KONSTANTINOS, METAXA-MARIATOU, VASILIKI, ZAROGOULIDIS, KONSTANTINOS, ZAROGOULIDIS, PAVLOS, KASARAKIS, DIMITRIOS, KAKOLYRIS, STYLIANOS, DAHABREH, JUBRAIL, VLASTOS, FOTIS, ZOUBLIOS, CHARALAMPOS, RAPTI, AGGELIKI, PAPAGEORGIOU, NIKI GEORGATOU, VELDEKIS, DIMITRIOS, GAGA, MINA, ARAVANTINOS, GERASIMOS, KARAVASILIS, VASILEIOS, KARAGIANNIDIS, NAPOLEON, NASIOULAS, GEORGE
Formato: Artigo
Idioma:Inglês
Publicado em: D.A. Spandidos 2015
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4579824/
https://ncbi.nlm.nih.gov/pubmed/26622815
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2015.3600
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados